Relationship between first pass effect NLR and PLR in mechanical thrombectomy for acute anterior circulation large-vessel occlusion.

Purpose: The study investigated the correlation between the neutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) concerning the first-pass effect (FPE) observed during mechanical thrombectomy subsequent to acute ischemic stroke (AIS).

Methods: Patients diagnosed with AIS in the anterior circulation, who underwent mechanical thrombectomy between January 2020 and December 2022, were assessed. Various data were collected, including blood cell counts, general information, relevant surgical and clinical details, and functional outcomes determined by the Modified Rankin Scale (MRS) score ≤2 at 3 months.

Study of Visual Quality and Higher Order Aberrations in Early Posterior Capsular Opacification.

This study aims to explore the visual quality and characteristics of higher order aberrations (HOAs) in patients with early posterior capsule opacification (PCO), providing a theoretical basis for the clinical assessment of early PCO and the potential benefits of Nd:YAG posterior capsulotomy. This cross-section observational study included 73 patients (73 eyes) diagnosed as PCO at a tertiary hospital from September 2022 to September 2023. All subjects underwent optometric examinations, OQAS, and iTrace measurements, followed by posterior capsule retroillumination photography after full mydriasis.

Endoscopic treatment for pancreatic diseases: Needle-knife-guided cannulation via the minor papilla.

Aim: To determine the efficacy and safety of meticulous cannulation by needle-knife.

Methods: Three needle-knife procedures were used to facilitate cannulation in cases when standard cannulation techniques failed. A total of 104 cannulations via the minor papilla attempted in 74 patients at our center between January 2008 and June 2014 were retrospectively reviewed.

Recombinant hemangiopoietin promotes cell adhesion and binds heparin in its multimeric form.

Hemangiopoietin (HAPO) is a novel growth factor stimulating the proliferation of hematopoietic and endothelial progenitor cells in vitro and in vivo. The native protein is a 294‑amino acid multimodular protein. The N‑terminus constitutes of two somatomedin B (SMB) homology domains that contain 14 cysteines.